LIDOCAINE HYDROCHLORIDE
| Brand name | AKTEN |
|---|---|
| Active ingredient | LIDOCAINE HYDROCHLORIDE |
| Strength | 3.5% |
| Dosage form | GEL |
| Route | OPHTHALMIC |
| Modality | Small molecule |
| FDA approval | October 2008 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8759401 | July 2026 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.